Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bodhi Tree Biotechnology (BDTB) Common Equity (2024 - 2025)

Bodhi Tree Biotechnology (BDTB) has disclosed Common Equity for 2 consecutive years, with $66213.0 as the latest value for Q4 2025.

  • Quarterly Common Equity fell 67.55% to $66213.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $66213.0 through Dec 2025, down 67.55% year-over-year, with the annual reading at $119161.0 for FY2025, N/A changed from the prior year.
  • Common Equity for Q4 2025 was $66213.0 at Bodhi Tree Biotechnology, down from $119161.0 in the prior quarter.
  • The five-year high for Common Equity was $204050.0 in Q4 2024, with the low at $66213.0 in Q4 2025.